FDAAdvisoryCommittee.com
March 10 & 11, 2010 - Pulmonary-Allergy Drugs Advisory Committee
long acting beta-2 adrenergic agonists review
Agenda: On March 10 and 11, 2010, the committee will discuss the design of medical research studies (known as ``clinical trial design'') to evaluate serious asthma outcomes (such as hospitalizations, a procedure using a breathing tube known as intubation, or death) with the use of the class of asthma medications known as long acting beta-2 adrenergic agonists in the treatment of asthma in adults, adolescents, and children.
Please Click HERE for our current calendar of upcoming events
To sign up for the live webcast, go to http://fdaac.com
FDAAdvisoryCommittee.com
No comments:
Post a Comment